There is a lot more guidance coming from FDA that recognizes that rare disease is a unique space for sponsors to design ...

Pathway to Cures (P2C), the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), encourages biotech and pharmaceutical companies that are developing treatments and cures for ...

Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

Royal Columbian Hospital Foundation’s AIM Institute (Advancing Innovation in Medicine) has partnered with the CAN Health Network to collaborate in supporting and scaling promising Canadian health ...

Close relatives of MS patients are 100 times more likely to develop the disorder than the general population, a study reports ...

Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated clinical, safety and tolerability profiles; SGT-003 has been generally well ...

Karan Arora, senior vice president of advanced assays, AI, and pharma services at Leica Biosystems outlines the critical role diagnostics have to play in unlocking the promise of precision medicine.

Executives from Definium Therapeutics (NASDAQ:DFTX) outlined clinical, regulatory, and commercial priorities for its lead psychedelic-derived program during a management discussion, emphasizing multip ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...

For households, digital spending often feels invisible. Subscriptions are typically spread across multiple platforms and paid automatically through bank cards or direct debits. Without a deliberate ...

Kathy Puyana Theall, M.D. and Adebola Giwa, M.D. bring deep expertise across oncology, rare diseases, and global clinical development to support advancement of Atossa's ...